Page last updated: 2024-08-17

tromethamine and Esophageal Neoplasms

tromethamine has been researched along with Esophageal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asanger, M; Honegger, H; Legay, R; Lukaschek, J; Malet-Martino, M; Martino, R; Maurer, D; Nufer, M; Widmer, L1
Concannon, MJ; Meng, L; Puckett, CL; Welsh, CF1

Other Studies

2 other study(ies) available for tromethamine and Esophageal Neoplasms

ArticleYear
Cardiotoxicity and neurotoxicity of high-dose continuous fluorouracil as a result of degradation compounds in the drug vials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Dec-15, Volume: 22, Issue:24

    Topics: Acetaldehyde; Aged; Antimetabolites, Antineoplastic; Brain Diseases; Carcinoma; Chemistry, Pharmaceutical; Esophageal Neoplasms; Excipients; Fatal Outcome; Female; Fluorouracil; Humans; Hyperammonemia; Male; Malonates; Middle Aged; Rectal Neoplasms; Tromethamine; Ventricular Dysfunction, Left

2004
Inhibition of perioperative platelet aggregation using toradol (ketorolac).
    Annals of plastic surgery, 1993, Volume: 30, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Squamous Cell; Contraindications; Drug Combinations; Esophageal Neoplasms; Esophagoplasty; Female; Humans; Ketorolac Tromethamine; Mandibular Neoplasms; Microsurgery; Middle Aged; Platelet Aggregation; Postoperative Complications; Tolmetin; Tromethamine

1993